AI41165/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
1998	2
1999	1
2025	0

Page 1

Fusion-competent vaccines: broad neutralization of primary isolates of HIV.

LaCasse RA, Follis KE, Trahey M, Scarborough JD, Littman DR, Nunberg JH. LaCasse RA, et al. Science. 1999 Jan 15;283(5400):357-62. doi: 10.1126/science.283.5400.357. Science. 1999. Retraction in: Science. 2002 May 10;296(5570):1025. doi: 10.1126/science.296.5570.1025b PMID: 9888845 Retracted.

Continued utilization of CCR5 coreceptor by a newly derived T-cell line-adapted isolate of human immunodeficiency virus type 1.

Follis KE, Trahey M, LaCasse RA, Nunberg JH. Follis KE, et al. J Virol. 1998 Sep;72(9):7603-8. doi: 10.1128/JVI.72.9.7603-7608.1998. J Virol. 1998. PMID: 9696861 Free PMC article.

Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity.

LaCasse RA, Follis KE, Moudgil T, Trahey M, Binley JM, Planelles V, Zolla-Pazner S, Nunberg JH. LaCasse RA, et al. J Virol. 1998 Mar;72(3):2491-5. doi: 10.1128/JVI.72.3.2491-2495.1998. J Virol. 1998. PMID: 9499111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year